To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Arcapta

FDA approved 75 ug once-daily Arcapta Neohaler indacaterol from Novartis AG (NYSE:NVS; SIX:NOVN) for the maintenance treatment of

Read the full 189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE